Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

Protein takes longer to digest than simple carbohydrates and helps stabilize blood sugar levels. High-protein foods include ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

orforglipron Eli Lilly competitor Novo Nordisk kicked off the weight-loss drug craze when it started selling Ozempic in the US in 2017. Back then, the once-weekly drug was only approved to treat ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

The Food and Drug Administration's approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1. Today ...